Thanks.
Most of these names are too small for us to endorse, and with limited liquidity, so investors should be well aware of the size risks here.
AKR, growth around single-digit, trading at 19x P/E, is still issuing shares. It costs a lot to be public, and with market cap at only $10M the costs are a big drag to the company. We don’t find AKR too attractive here.
BEW has better great momentum, and decent growth. It is profitable with positive cash flow. At 12X earnings, we would consider it the best of this group, but is still too small to highly endorse.
SECU: though growth was strong in recent quarters, it is still unprofitable and had minimal cash flow in the most recent trailing-twelve-month period. It is larger at $50M. The balance sheet is strong with excess cash and the revenue base is fairly large. Insiders own 35%. We would consider it 'OK' but not compelling. It is losing money so a P/E valuation is not useful. It is very cheap on a price/sales basis, but that's because margins are very low.